iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Option Chain

Add as a Preferred Source on Google
2,039.7
(-4.54%)
Mar 4, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
3,0000%₹354 0%1,700--
--1,720₹3.25 160%1,500100%
--1,740₹3 0%4,1250%
--1,760₹1.95 0%11,6250%
--1,780₹9 200%2,625-12.5%
1,5000%₹295.3 0%1,800₹8.25 184.48%13,87512.12%
--1,820₹4.7 17.5%1,125-40%
--1,840₹12 220%18,000-7.69%
3750%₹202 0%1,860₹14.55 219.78%19,500-16.12%
4,125-8.33%₹238 36%1,880--
12,0000%₹172 1.17%1,900₹21 220.61%49,875-29.25%
1,5000%₹190 -12.82%1,920₹25 216.45%15,00029.03%
--1,940₹11.5 -68.05%7500%
--1,960₹34.7 200.43%18,750-18.03%
1,1250%₹118.5 0%1,980--
1,23,750-5.17%₹95.65 -42.24%2,000₹48.75 191.04%1,02,375-10.78%
8,2500%₹164.15 0%2,020₹56.5 168.4%24,37516.07%
43,12540.24%₹74.85 -44.43%2,040₹65 163.69%64,12547.41%
1,57,500183.78%₹64 -45.71%2,060₹76.3 155.18%1,38,375136.53%
25,50015.25%₹54.9 -47.91%2,080₹87 146.11%29,250-12.35%
2,44,50039.01%₹46.25 -49.5%2,100₹95 116.4%76,125-12.87%
50,62550%₹38.15 -52.1%2,120₹111.1 115.93%24,375-7.14%
97,12513.59%₹32.15 -53.33%2,140₹124.2 104.95%38,625-34.39%
65,6255.42%₹28.45 -52.54%2,160₹128.4 83.95%22,875-3.17%
39,00035.06%₹22 -56.65%2,180--
1,99,87511.97%₹18.9 -55.99%2,200₹171.3 80.12%22,125-13.23%
30,00066.66%₹15.15 -57.68%2,220--
61,87532%₹12.45 -59.18%2,240₹169.85 0%2,6250%
30,75049.09%₹10 -60.15%2,260₹129.3 -5.03%3,7500%
1,05,37524.88%₹8 -62.61%2,280--
80,25031.28%₹6.45 -64.46%2,300--
73,875-20.56%₹5.4 -63.75%2,320₹200.75 0%28,1250%
63,750-9.09%₹3.3 -68.72%2,360--
55,875-30.04%₹2.4 -67.34%2,400--

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.